What Researchers Did
Researchers conducted a prospective observational study with 40 acute carbon monoxide poisoning patients to compare initial and post-treatment serum neuron-specific enolase (NSE) and S-100β levels after normobaric oxygen (NBO) or hyperbaric oxygen (HBO) therapy.
What They Found
Serum NSE and S-100β values significantly decreased in both the 20 NBO and 20 HBO patient groups after treatment. The initial and post-treatment levels of NSE and S-100β were comparable between the NBO and HBO therapies. A clear negative correlation was observed between the decrease of these markers and initial blood carboxyhemoglobin levels.
What This Means for Canadian Patients
For Canadian patients experiencing carbon monoxide poisoning, monitoring serum S-100β and NSE levels could help assess brain injury and track recovery. These markers may serve as useful indicators of treatment effectiveness, regardless of whether normobaric or hyperbaric oxygen is administered.
Canadian Relevance
This study has no direct Canadian connection as it was conducted in another country and does not involve Canadian researchers or participants.
Study Limitations
The study's observational design and relatively small sample size of 40 patients limit the generalizability of its findings regarding treatment efficacy.